Search research articles
Contact Us
Filters
Showing results (131-140 of 149) with videos related to
Page
of 15
Sort By:
The Journal of Clinical Investigation
|
May 11, 2023
PP2A modulation overcomes multidrug resistance in chronic lymphocytic leukemia via mPTP-dependent apoptosis
Kallesh D Jayappa, Brian Tran, Vicki L Gordon, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 10, 2021
Alterations in sphingolipid composition and mitochondrial bioenergetics represent synergistic therapeutic vulnerabilities linked to multidrug resistance in leukemia
Kelsey H Fisher-Wellman, James T Hagen, Miki Kassai, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
July 5, 2017
Effective encapsulation and biological activity of phosphorylated chemotherapeutics in calcium phosphosilicate nanoparticles for the treatment of pancreatic cancer
Welley S Loc, Samuel S Linton, Zachary R Wilczynski, et al.
Journal of Lipid Research
|
May 4, 2016
Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemia
Samy A F Morad, Terence E Ryan, P Darrell Neufer, et al.
Hepatology (Baltimore, Md.)
|
September 8, 2011
Regression of established hepatocellular carcinoma is induced by chemoimmunotherapy in an orthotopic murine model
Diego M Avella, Guangfu Li, Todd D Schell, et al.
Cancer Translational Medicine
|
September 12, 2017
SKI-178: A Multitargeted Inhibitor of Sphingosine Kinase and Microtubule Dynamics Demonstrating Therapeutic Efficacy in Acute Myeloid Leukemia Models
Jeremy A Hengst, Taryn E Dick, Arati Sharma, et al.
Plos One
|
December 25, 2013
C6-ceramide nanoliposomes target the Warburg effect in chronic lymphocytic leukemia
Lindsay K Ryland, Ushma A Doshi, Sriram S Shanmugavelandy, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
September 15, 2022
Ceramide nanoliposomes augment the efficacy of venetoclax and cytarabine in models of acute myeloid leukemia
Andrei V Khokhlatchev, Arati Sharma, Tye G Deering, et al.
Blood Reviews
|
April 29, 2022
Harnessing the power of sphingolipids: Prospects for acute myeloid leukemia
Johnson Ung, Su-Fern Tan, Todd E Fox, et al.
Oncotarget
|
September 12, 2022
Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma
Francis R LeBlanc, Zainul S Hasanali, August Stuart, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 149) with videos related to
Sort By:
Page
of 15
The Journal of Clinical Investigation
|
May 11, 2023
PP2A modulation overcomes multidrug resistance in chronic lymphocytic leukemia via mPTP-dependent apoptosis
Kallesh D Jayappa, Brian Tran, Vicki L Gordon, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 10, 2021
Alterations in sphingolipid composition and mitochondrial bioenergetics represent synergistic therapeutic vulnerabilities linked to multidrug resistance in leukemia
Kelsey H Fisher-Wellman, James T Hagen, Miki Kassai, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
July 5, 2017
Effective encapsulation and biological activity of phosphorylated chemotherapeutics in calcium phosphosilicate nanoparticles for the treatment of pancreatic cancer
Welley S Loc, Samuel S Linton, Zachary R Wilczynski, et al.
Journal of Lipid Research
|
May 4, 2016
Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemia
Samy A F Morad, Terence E Ryan, P Darrell Neufer, et al.
Hepatology (Baltimore, Md.)
|
September 8, 2011
Regression of established hepatocellular carcinoma is induced by chemoimmunotherapy in an orthotopic murine model
Diego M Avella, Guangfu Li, Todd D Schell, et al.
Cancer Translational Medicine
|
September 12, 2017
SKI-178: A Multitargeted Inhibitor of Sphingosine Kinase and Microtubule Dynamics Demonstrating Therapeutic Efficacy in Acute Myeloid Leukemia Models
Jeremy A Hengst, Taryn E Dick, Arati Sharma, et al.
Plos One
|
December 25, 2013
C6-ceramide nanoliposomes target the Warburg effect in chronic lymphocytic leukemia
Lindsay K Ryland, Ushma A Doshi, Sriram S Shanmugavelandy, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
September 15, 2022
Ceramide nanoliposomes augment the efficacy of venetoclax and cytarabine in models of acute myeloid leukemia
Andrei V Khokhlatchev, Arati Sharma, Tye G Deering, et al.
Blood Reviews
|
April 29, 2022
Harnessing the power of sphingolipids: Prospects for acute myeloid leukemia
Johnson Ung, Su-Fern Tan, Todd E Fox, et al.
Oncotarget
|
September 12, 2022
Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma
Francis R LeBlanc, Zainul S Hasanali, August Stuart, et al.
Page
of 15